Couverture de WolverHeme Happy Hour

WolverHeme Happy Hour

WolverHeme Happy Hour

De : Bernard Marini Anthony Perissinotti et al.
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

 Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.Bernard Marini, Anthony Perissinotti, et al. Hygiène et vie saine Maladie et pathologies physiques
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • ASH Leukemia Review: the more we learn, the less we know!

      ASH Leukemia Review: the more we learn, the less we know!
      Dec 17 2025

      In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts should change practice? Listen to find out.


      Some of the abstracts discussed:

      • PARADIGM: https://meetings-api.hematology.org/api/abstract/vmpreview/296881
      • KMT2A Outcomes (MARROW Consortium and Othman, et al.): https://meetings-api.hematology.org/api/abstract/vmpreview/302582 and https://meetings-api.hematology.org/api/abstract/vmpreview/297333
      • CLIA +/- Ven: https://meetings-api.hematology.org/api/abstract/vmpreview/302047
      • FLT3i studies (and MRD): https://meetings-api.hematology.org/api/abstract/vmpreview/295719 and https://meetings-api.hematology.org/api/abstract/vmpreview/302699 and https://meetings-api.hematology.org/api/abstract/vmpreview/291322
      • ALL GIMEMA Trial (blin + ponatinib): https://meetings-api.hematology.org/api/abstract/vmpreview/296532
      • Menin inhibitor data
      Afficher plus Afficher moins
      1 h et 23 min
    • RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy

      RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy
      Dec 9 2025

      Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice.

      https://meetings-api.hematology.org/api/abstract/vmpreview/296881

      Afficher plus Afficher moins
      41 min
    • MajesTEC-3 and ASH 2025: Let's get "TEC"nical

      MajesTEC-3 and ASH 2025: Let's get "TEC"nical
      Nov 25 2025

      In this study, Bernie and Anthony are joined by the majestic myeloma man Manni Mohyuddin to discuss key ASH abstracts in myeloma, including the results of the MajesTEC-3 study!

      Afficher plus Afficher moins
      1 h et 10 min
    Aucun commentaire pour le moment